Daniel G. Welch
Board Member
Prothena Corp Public Ltd Co (PRTA)Board Member
Ultragenyx Pharmaceutical Inc. (RARE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Daniel G. Welch
Daniel G. Welch is recorded as Board Member at Prothena Corp Public Ltd Co (PRTA) and Board Member at Ultragenyx Pharmaceutical Inc. (RARE). Daniel G. Welch was last confirmed as Board Member at Nuvation Bio Inc. (NUVB) in a filing dated July 30, 2024. Ultragenyx Pharmaceutical Inc. reported in an 8-K filed May 18, 2026 that Daniel G. Welch was appointed Class I Director, effective May 14, 2026. Prothena Corp Public Ltd Co reported in an 8-K filed February 21, 2024 that Daniel G. Welch was appointed director, effective February 21, 2024. Ultragenyx Pharmaceutical Inc. reported in an 8-K filed June 13, 2023 that Daniel G. Welch was appointed Class I Director, effective June 7, 2023.
“At the Annual Meeting, the Company's stockholders elected the Class I director nominees below to the Company's Board of Directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected.”
“On February 21, 2024, the Board of Directors (the "Board") of Prothena Corporation plc (the "Company") increased the size of the Board and appointed Daniel G. Welch to serve as a director of the Company, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Current
Start not stated–present
-
Nuvation Bio Inc. (NUVB)
Proxy statement
Start not stated–2024-07-30
Last confirmed by a filing; no departure on record
-
Start not stated–2024-07-30
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Prothena Corp Public Ltd Co
Other people whose current roles at this company are on record from its filings.
- Gene Kinney CEO, Board Member
- Lars G. Ekman Chairman, Board Member
- Brandon S. Smith COO, Board Member
- Brandon Smith Board Member
- Carol D. Karp Board Member
- Dennis J. Selkoe Board Member
- Helen S. Kim Board Member
- Richard T. Collier Board Member
- Sanjiv K. Patel, Ph.D. Board Member
- Shane M. Cooke Board Member
Leadership on record at Ultragenyx Pharmaceutical Inc.
Other people whose current roles at this company are on record from its filings.
- Emil D. Kakkis CEO, Board Member
- Emil Kakkis CEO, Board Member
- Howard Horn CFO
- Eric Crombez, M.D. CTO
- Karah Parschauer General Counsel
- Amrit Ray, M.D. Board Member
- Clay B. Siegall Board Member
- Continuing Directors Board Member
- Corazon (Corsee) D. Sanders, Ph.D. Board Member
- Corsee Sanders, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.